Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Declines By 99.2%

3SBio Inc. (OTCMKTS:TRSBF) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,000 shares, a decrease of 99.2% from the February 29th total of 133,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

3SBio Price Performance

Shares of OTCMKTS TRSBF opened at $0.80 on Thursday. 3SBio has a twelve month low of $0.80 and a twelve month high of $0.80. The firm has a 50-day moving average of $0.80 and a two-hundred day moving average of $0.80.

About 3SBio

3SBio Inc, an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis.